Cancer Drug Prevents Build-Up of Toxic Brain Protein Linked to Parkinsonís Disease
(June 13, 2013) – Researchers at Georgetown University Medical Center have found that a chemotherapy treatment for adults with leukemia may hold potential to treat people with Parkinson’s disease (PD), according to an early study published May 10 in Human Molecular Genetics. In mice, the drug was able to reduce levels of a harmful protein in the brain and improve motor symptoms. Scientists have not yet determined the drug’s potential for people living with PD, but this early study in mice offers hope.
Click here for the full press release from Georgetown University Medical Center.